Rheological Behavior of Pharmaceutical-grade Cellulose Ethers and Its Impact on Excipient Selection in Drug Formulations

Abstract

Background & Scope: Pharmaceutical-grade cellulose ethers, such as hydroxypropyl methylcellulose (HPMC) and hydroxypropyl cellulose (HPC), are widely used as excipients due to their effects on viscosity, mechanical strength, hydration behavior, and drug release performance. In formulation development, excipient selection is commonly based on nominal viscosity grades; however, steady shear viscosity alone does not adequately describe the time dependent and deformation sensitive behavior that governs critical quality attributes and in-process performance. Methodology: A comprehensive rheological evaluation of multiple HPMC and HPC grades obtained from different manufacturers was performed by preparing different concentrations of polymeric dispersions using steady shear and oscillatory rheometry. Flow sweep, amplitude sweeps, and frequency sweep analysis were conducted to characterize viscosity, viscoelastic behavior, and structural response under varying deformation conditions. Results & Discussion: All cellulose ether samples exhibited non-Newtonian, shear thinning behavior. Distinct differences in viscoelastic properties were observed between polymer types and grades. HPMC demonstrated molecular weight and concentration dependent transitions toward elastic dominated, gel like behavior, while HPC remained predominantly viscous dominated under comparable experimental conditions. The observed differences in rheological behavior highlight the limitations of relying solely on nominal viscosity grades for excipient selection. Advanced rheological parameters, particularly viscoelastic characteristics, provide deeper insight into polymer structure property relationships and their impact on formulation performance. Conclusion: This study underscores the importance of comprehensive rheological profiling beyond steady shear viscosity to support rational excipient selection and the design of robust pharmaceutical formulations involving cellulose ether polymers.